Mural Oncology plc (MURA)

Mural Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	111.02	270.85	-	-
Cash & Short-Term Investments	175.5	270.85	-	-
Other Receivables	2.14	6.34	1.8	2
Receivables	2.14	6.34	1.8	2
Prepaid Expenses	6.15	0.15	2.99	2.2
Other Current Assets	-	-	0.03	0.04
Total Current Assets	183.79	277.34	4.82	4.24
Property, Plant & Equipment	17.48	24.15	28.93	30.87
Other Long-Term Assets	2	0.26	-	-
Total Assets	203.27	301.75	33.75	35.11
Accounts Payable	2.24	5.97	2.97	10.59
Accrued Expenses	17.21	16.95	32.75	16.74
Current Portion of Leases	5.44	6.1	5.84	5.92
Total Current Liabilities	24.91	29.02	41.56	33.25
Long-Term Leases	4.1	8.91	13.54	19.39
Other Long-Term Liabilities	0.12	-	0.3	0.36
Total Liabilities	29.13	37.93	55.41	52.99
Common Stock	0.17	0.17	-21.66	-17.88
Additional Paid-In Capital	299.02	294.51	-	-
Retained Earnings	-125.1	-30.86	-	-
Shareholders' Equity	174.14	263.82	-21.66	-17.88
Total Liabilities & Equity	203.27	301.75	33.75	35.11
Total Debt	9.55	15.01	19.39	25.31
Net Cash (Debt)	165.96	255.84	-19.39	-25.31
Net Cash Per Share	9.84	15.33	-1.16	-
Filing Date Shares Outstanding	17.06	16.92	16.69	-
Total Common Shares Outstanding	17.04	16.69	16.69	-
Working Capital	158.88	248.32	-36.74	-29.01
Book Value Per Share	10.22	15.81	-1.30	-
Tangible Book Value	174.14	263.82	-21.66	-17.88
Tangible Book Value Per Share	10.22	15.81	-1.30	-
Machinery	-	21.74	17.47	13.6
Construction In Progress	-	0.02	1.99	1.97
Leasehold Improvements	-	23.33	22.51	20.88

Source: S&P Capital IQ. Standard template. Financial Sources.